Sort   by:  
 Page size 
UnknownMetabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma.
Not available
S-EPMC8577318 | biostudies-literature
UnknownLeukemia mutated proteins PHF6 and PHIP form a chromatin complex that represses acute myeloid leukemia stemness.
Not available
S-EPMC12340699 | biostudies-literature
UnknownTrib2 Suppresses Tumor Initiation in Notch-Driven T-ALL.
Not available
S-EPMC4871414 | biostudies-literature
UnknownCBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
Not available
S-EPMC5495118 | biostudies-literature
UnknownA proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma.
Not available
S-EPMC11560519 | biostudies-literature
UnknownTargeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma.
Not available
S-EPMC6277197 | biostudies-literature
UnknownNeuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.
Not available
S-EPMC5258837 | biostudies-literature
UnknownPhase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.
Not available
S-EPMC4066886 | biostudies-literature
Sort   by:  
 Page size